Search results for "medwatch"


 
Results 1 - 10 of about 10 for "medwatch".

Bleeding risk of dabigatran under scrutiny

Serious bleeding events have been reported in patients taking dabigatran (Pradaxa), according to a new FDA MedWatch alert.
December 2011

New warning about fluoroquinolones

Clinicians can report adverse events through MedWatch or by contacting their local FDA district office consumer complaint coordinator.
July 2016

FDA reviewing safety of HIV drug combo

Health care professionals and patients are also encouraged to report any adverse events or side effects to the FDA MedWatch.
March 2010

Propofol, ventilators, infusion sets recalled

If retained tissue is discovered, facilities should file a voluntary report with MedWatch, the FDA Safety Information and Adverse Reporting program online.
September 2009

CDC offers updated guidance on national meningitis outbreak

Any suspected adverse events should be reported to the FDA's MedWatch program.
October 2012

Quick response, teamwork protected patients during heparin recall

In its heparin alert, the FDA called on clinicians to watch patients receiving heparin closely and report all adverse events to MedWatch, the FDA's online system.
July 2008

PPIs get warning on fracture risk

Any side effects or other product problems with PPIs should be reported via the FDA's MedWatch Adverse Event Reporting program or by calling 800-332-1088.
June 2010

Proton-pump inhibitors to carry warning about C. diff

The FDA warned last week that proton-pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile–associated diarrhea (CDAD).
February 2012

Journal watch: recent studies of note

Louis and found an association with gadolinium. As of Dec. 25, 2006, the FDA MedWatch system had received 90 reports of NSF possibly related to gadolinium-containing contrast agents.
April 2007

New anticoagulants getting expanded approval, but also review

Healthcare professionals should remain vigilant for cases of malignancy in patients treated with TNF blockers and report them to the FDA MedWatch program or to the manufacturer.
February 2012

Result Page: Prev   1   Next